cp wire

CP Wire Articles

Basilea Enters Collaboration With Roche to Study BAL087 in Combination With Tecentriq in Urothelial Cancer
  • ArQule is eligible to receive up to $326 million in regulatory and commercial milestone payments related to the BAL087 license agreement
  • BAL087 has U.S. and EU orphan drug... read more
Thu, 01/24/19 - 10:38 am
Evotec Receives Milestone Payment for Beginning Phase II NASH Clinical Trial

Evotec AG (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) announced today that it has earned a $ 2 m milestone payment from Second Genome, Inc., a leading microbiome science-based... read more

Thu, 01/24/19 - 10:12 am
Vedanta Biosciences Publishes Seminal Research in Leading Scientific Journal Regarding its Immuno-oncology Candidate, VE800
  • The research demonstrates that specific, human microbiome-derived bacteria assembled rationally into consortia can cooperatively enhance the responses to immune checkpoint inhibitors
    • ... read more
Thu, 01/24/19 - 12:19 am
Gosssamer Bio to Use 20 Day Rule for $230 Million IPO

Gossamer Bio announced terms for it's $230 Million IPO on 1/23/19. The company plans to offer 14.4 million shares at $16 per share. Insiders have expressed an interest in acquiring $100 million of... read more

Wed, 01/23/19 - 09:14 pm
Talee Bio Receives $4.5 Million from the Cystic Fibrosis Foundation to Expedite Development of Two Gene Therapy Candidates

Talee Bio, Inc. announced on 1/23/19 agreements with the Cystic Fibrosis Foundation (CF Foundation) to fund the preclinical development of two mutation-agnostic gene therapy product candidates, TL... read more

Wed, 01/23/19 - 09:37 am

Pages